Clinical Trials Sponsored by Tauber Eye Center
Total 1846 results
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; United... and other collaboratorsCompletedBreast Cancer | Menopause | Postmenopausal Bone LossUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Mayo Clinic; Northwell Health; Duke University; National... and other collaboratorsActive, not recruitingOther CancerUnited States
-
University of MichiganM.D. Anderson Cancer Center; National Cancer Institute (NCI); Dana-Farber Cancer... and other collaboratorsCompletedBarrett's EsophagusUnited States, Canada
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Stanford University and other collaboratorsCompletedCigarette Smoking BehaviorUnited States
-
Shenzhen SiBright Co., Ltd.Peking University People's Hospital; Zhongshan Ophthalmic Center, Sun Yat-sen... and other collaboratorsUnknown
-
Andrew E. Place, MDUniversity of Colorado, Denver; AbbVie; Boston Children's Hospital; Gateway for... and other collaboratorsRecruitingAcute Lymphoblastic Leukemia, in Relapse | Therapy-Related Myelodysplastic Syndrome | Acute Leukemia of Ambiguous Lineage | Acute Leukemia of Ambiguous Lineage in Relapse | Myelodysplastic Syndromes, Previously Treated | Acute Lymphoblastic Leukemia With Failed Remission | Myelodysplastic Syndromes... and other conditionsUnited States
-
Smith-Kettlewell Eye Research InstituteThe University of Texas Health Science Center, Houston; University of Oklahoma and other collaboratorsCompletedDevelopment of Side Effects From Betaxolol
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; University of California, Los Angeles; Dana-Farber... and other collaboratorsActive, not recruiting
-
Dana-Farber Cancer InstituteHarvard University; Conquer Cancer Foundation; Alex's Lemonade Stand Foundation; Sam Day FoundationRecruitingEwing Sarcoma of Bone | Ewing Sarcoma | Peripheral Primitive Neuroectodermal Tumor | Peripheral Primitive Neuroectodermal Tumor of Bone | High-grade Osteosarcoma | Ewing Sarcoma of Soft Tissue | Peripheral Primitive Neuroectodermal Tumor of Soft TissueUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer Institute; AstraZeneca; Brigham...CompletedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); AstraZeneca; Genentech, Inc.; National Institutes...Active, not recruitingChronic Lymphocytic Leukemia (CLL)United States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); National Institute of Allergy and Infectious...CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Nancy Lin, MDGlaxoSmithKline; Brigham and Women's Hospital; Breast Cancer Research FoundationCompletedBreast Cancer | Brain MetastasesUnited States
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research...CompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Nancy Lin, MDBayer; Brigham and Women's Hospital; Breast Cancer Research FoundationTerminatedBreast Cancer | CNS DiseaseUnited States
-
Harold J. Burstein, MD, PhDMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Mayo Clinic; Baylor College... and other collaboratorsCompleted
-
Beth Israel Deaconess Medical CenterRambam Health Care Campus; Dana-Farber Cancer Institute; United States Department... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States, Israel
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsCompleted
-
Craig A. Bunnell, MD, MPHMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...EHE Rare Cancer Charity UKRecruitingSarcoma,Soft Tissue | Epithelioid HemangioendotheliomaUnited Kingdom, Italy, Denmark, Spain, Sweden, Austria, Germany, France, Norway, Poland
-
Medical College of WisconsinMemorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute; University... and other collaboratorsCompletedLeukemia, Myeloid, ChronicUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Shandong University of Traditional Chinese MedicineNot yet recruiting
-
Brigham and Women's HospitalDana-Farber Cancer Institute; United States Department of DefenseNot yet recruiting
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaRecruitingBreast Cancer Stage I | Breast Cancer Stage II | Acupuncture | Breast Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast CancerUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Pharmacyclics LLC.Completed
-
Patrick Ott, MD, PhDBristol-Myers Squibb; Oncovir, Inc.Active, not recruiting
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's HospitalCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
James Cleary, MD, PhDLustgarten Foundation; Arcus Biosciences, Inc.RecruitingPancreatic Cancer | Adenocarcinoma of the Pancreas | Squamous Cell Carcinoma of Pancreas | Adenosquamous Carcinoma of the PancreasUnited States
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaActive, not recruitingBreast CancerUnited States
-
Boston Children's HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Schering-PloughCompletedProgeria | Hutchinson-Gilford SyndromeUnited States
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier TherapeuticsTerminatedBladder CancerUnited States
-
Suzanne George, MDNovartis; Pfizer; Brigham and Women's HospitalCompletedSarcoma | Solid TumorUnited States
-
Vital Art and Science IncorporatedNational Eye Institute (NEI); University of Texas Southwestern Medical Center; Retina Foundation of the Southwest and other collaboratorsCompletedDiabetic Retinopathy | Diabetic Macular EdemaUnited States
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis PharmaceuticalsRecruitingBreast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast TripleUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalActive, not recruitingCAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerGastric Cancer | Esophageal CancerUnited States
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZenecaCompletedSolid TumorUnited States
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaCompletedStage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral NeuropathyUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's HospitalCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome-Refractory Anemia With Excess BlastsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedStomach Cancer | Esophageal CancerUnited States
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR); University of WashingtonCompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; University of Virginia; Schering-PloughCompletedGlioma | Astrocytoma | OligodendrogliomaUnited States